Skip to content
← Holders

Rosalind Advisors, Inc.

What Rosalind Advisors, Inc. reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1622627 · Filed Nov 16, 2026

Positions
46
Reported value
$311.9M
Opened
15
Closed
4
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$292.6M
    39 positions
  2. Dec 31, 2025$284.5M
    42 positions
  3. Mar 31, 2026$248.9M
    38 positions
  4. Jun 30, 2026$269.2M
    35 positions
  5. Sep 30, 2026$311.9M
    46 positions
SecuritySharesChangeValueOf portfolio
DCTHDelcath Systems, Inc.
3.3M±0%$52.7M16.9%
VSTMVerastem, Inc.
4.2M+6.3%$34.1M10.9%
FENCFennec Pharmaceuticals Inc.
3.2M±0%$34M10.9%
XERSXeris Biopharma Holdings, Inc.
2.6M−11.2%$24.7M7.9%
HELPHelus Pharma Inc.
1.4M−29.1%$17.1M5.5%
SVRASavara Inc
3.2M±0%$16.4M5.3%
REPLReplimune Group, Inc.
1MNew$13.2M4.2%
VORVor Biopharma Inc.
609.2K−6.1%$11.6M3.7%
MDWDMediWound Ltd.
749.1K±0%$10.3M3.3%
XFORX4 Pharmaceuticals, Inc
3.2M±0%$9.3M3%
AQSTAquestive Therapeutics, Inc.
2M+700.0%$9.3M3%
PCVXVaxcyte, Inc.
149.4K−25.3%$8.5M2.7%
TARAProtara Therapeutics, Inc.
2.4MNew$7.3M2.3%
MYOMyomo, Inc.
3.9M+7.7%$6.1M2%
BCRXBiocryst Pharmaceuticals Inc
721.5K±0%$6M1.9%
RCKTRocket Pharmaceuticals, Inc.
2.2MNew$5.8M1.9%
PEPGPepGen Inc.
2M+471.4%$4.8M1.6%
PROFProfound Medical Corp.
828.1K±0%$4.8M1.5%
TLPHTalphera, Inc.
4.1M−20.0%$4.8M1.5%
NRXSNeuraxis, INC
548.1K+7.9%$4M1.3%
OVIDOvid Therapeutics Inc.
1.1M±0%$2.8M0.9%
NSPRInspireMD, Inc.
3.9M±0%$2.6M0.8%
ABOSAcumen Pharmaceuticals, Inc.
1.1MNew$2.4M0.8%
EYPTEyePoint, Inc.
696K−29.6%$2.3M0.7%
ABVXAbivax S.A.
20.9K±0%$2.1M0.7%
BFRIBiofrontera Inc.
1.8M+40.3%$1.9M0.6%
FEMYFemasys Inc
759.2KNew$1.6M0.5%
AVIRAtea Pharmaceuticals, Inc.
280.1K−73.8%$1.5M0.5%
CGONCG Oncology, Inc.
20KNew$1.4M0.5%
SPRBSpruce Biosciences, Inc.
26.5K+32.6%$1.3M0.4%
RGNTRegentis Biomaterials Ltd.
701.7K±0%$1.3M0.4%
KURAKura Oncology, Inc.
100K±0%$1.1M0.3%
GRCEGrace Therapeutics, Inc.
476.2KNew$1M0.3%
PYPDPolyPid Ltd.
177K−54.5%$932.8K0.3%
SPDR SERIES TRUSTPUTPut option
250K+77.8%$925K0.3%
STATE STR SPDR S&P 500 ETF TPUTPut option
100KNew$382K0.1%
VERASTEM INCCALLCall option
293.6KNew$356.5K0.1%
INVESCO QQQ TRPUTPut option
50KNew$257.5K0.1%
PEPGEN INCCALLCall option
412.7KNew$256.9K0.1%
OKUROnKure Therapeutics, Inc.
67.5K−55.0%$184K0.1%
XERIS BIOPHARMA HOLDINGS INCCALLCall option
400KNew$160K0.1%
SELLAS LIFE SCIENCES GROUP INCPUTPut option
618.8K+8.8%$127K0.1%
BRISTOL-MYERS SQUIBB COCALLCall option
20KNew$84.2K0.1%
EYEPOINT INCCALLCall option
701.7K+1,295.0%$50K0.1%
CORCEPT THERAPEUTICS INCPUTPut option
10KNew$23.5K0.1%
CELLDEX THERAPEUTICS INCPUTPut option
128.8KNew$00%